Valuation (40%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 212.93 | 24.94 |
| PEG Ratio (TTM) | 1.72 | 0.08 |
| P/S Ratio (TTM) | 0.46 | 0.99 |
| P/B Ratio (TTM) | 3.39 | 3.85 |
| P/FCF Ratio (TTM) | 13.21 | 41.65 |
| Price to 5YR AVG Earnings Ratio | N/A | 24.26 |
| Price to 5YR AVG FCF Ratio | N/A | 17.95 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.38% | 5.51% |
| ROE (TTM) | 1.86% | 18.01% |
| Net Profit Margin (TTM) | 0.25% | 4.26% |
| ROIC 5YR AVG | N/A | 19.71% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -72.34% | -44.53% | N/A |
| Revenue | 11.82% | 115.68% | N/A |
| Net Income | -75.17% | -34.30% | N/A |
| Cash Flow | -144.11% | 120.79% | N/A |
Health (35%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.96 | 0.66 |
| Quick Ratio (TTM) | 1.77 | 1.02 |
| D/E Ratio (TTM) | 0.26 | 0.75 |
| Interest Coverage (TTM) | 2.05 | -4.31 |
| Piotroski F-Score | 2 | 7 |
| Altman Z-Score | 1.29 | 2.79 |
| LTL to 5YR AVG FCF | N/A | 3.09 |
| Shares Outstanding Growth 5YR AVG | N/A | 0.52% |